The Role of Nonpharmacological Interventions in Treatment-resistant Depression

Thomas E. Schlaepfer, Sarah Kayser

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

In approximately 50% of patients suffering from major depressive disorder (MDD), first-line antidepressant treatment is ineffective, and in about 30% of MDD patients, even four treatment steps yield insufficient antidepressant response. Stimulation of the human cerebral cortex with electrical currents was first described in 1874. In 1938, electroconvulsive therapy (ECT) was first used for the treatment of depression and about 50 years later transcranial magnetic stimulation (TMS) for the same purpose was successfully accomplished. Today, ECT is established as one of the main columns in treatment-resistant depression (TRD) therapy. However, due to cognitive side effects and stigmatization, ECT is often used as a treatment of last resort. In recent years, novel techniques using electrical and magnetic fields to stimulate the brain have been developed. This chapter examines the use of ECT, TMS, vagus nerve stimulation (VNS), deep-brain stimulation (DBS) and magnetic seizure therapy (MST).

Original languageEnglish (US)
Title of host publicationTreatment-resistant Depression
PublisherJohn Wiley and Sons
Pages159-182
Number of pages24
ISBN (Print)9781119952909
DOIs
StatePublished - Feb 5 2013

Fingerprint

Treatment-Resistant Depressive Disorder
Electroconvulsive Therapy
Transcranial Magnetic Stimulation
Major Depressive Disorder
Antidepressive Agents
Therapeutics
Vagus Nerve Stimulation
Stereotyping
Deep Brain Stimulation
Magnetic Fields
Cerebral Cortex
Seizures
Depression
Brain

Keywords

  • Brain stimulation methods
  • Deep brain stimulation
  • Electroconvulsive therapy
  • Magnetic seizure therapy
  • Transcranial magnetic stimulation
  • Vagus nerve stimulation

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Schlaepfer, T. E., & Kayser, S. (2013). The Role of Nonpharmacological Interventions in Treatment-resistant Depression. In Treatment-resistant Depression (pp. 159-182). John Wiley and Sons. https://doi.org/10.1002/9781118556719.ch7

The Role of Nonpharmacological Interventions in Treatment-resistant Depression. / Schlaepfer, Thomas E.; Kayser, Sarah.

Treatment-resistant Depression. John Wiley and Sons, 2013. p. 159-182.

Research output: Chapter in Book/Report/Conference proceedingChapter

Schlaepfer, TE & Kayser, S 2013, The Role of Nonpharmacological Interventions in Treatment-resistant Depression. in Treatment-resistant Depression. John Wiley and Sons, pp. 159-182. https://doi.org/10.1002/9781118556719.ch7
Schlaepfer, Thomas E. ; Kayser, Sarah. / The Role of Nonpharmacological Interventions in Treatment-resistant Depression. Treatment-resistant Depression. John Wiley and Sons, 2013. pp. 159-182
@inbook{1fa5d6bcdaff4093b519c3f3f86c8db3,
title = "The Role of Nonpharmacological Interventions in Treatment-resistant Depression",
abstract = "In approximately 50{\%} of patients suffering from major depressive disorder (MDD), first-line antidepressant treatment is ineffective, and in about 30{\%} of MDD patients, even four treatment steps yield insufficient antidepressant response. Stimulation of the human cerebral cortex with electrical currents was first described in 1874. In 1938, electroconvulsive therapy (ECT) was first used for the treatment of depression and about 50 years later transcranial magnetic stimulation (TMS) for the same purpose was successfully accomplished. Today, ECT is established as one of the main columns in treatment-resistant depression (TRD) therapy. However, due to cognitive side effects and stigmatization, ECT is often used as a treatment of last resort. In recent years, novel techniques using electrical and magnetic fields to stimulate the brain have been developed. This chapter examines the use of ECT, TMS, vagus nerve stimulation (VNS), deep-brain stimulation (DBS) and magnetic seizure therapy (MST).",
keywords = "Brain stimulation methods, Deep brain stimulation, Electroconvulsive therapy, Magnetic seizure therapy, Transcranial magnetic stimulation, Vagus nerve stimulation",
author = "Schlaepfer, {Thomas E.} and Sarah Kayser",
year = "2013",
month = "2",
day = "5",
doi = "10.1002/9781118556719.ch7",
language = "English (US)",
isbn = "9781119952909",
pages = "159--182",
booktitle = "Treatment-resistant Depression",
publisher = "John Wiley and Sons",

}

TY - CHAP

T1 - The Role of Nonpharmacological Interventions in Treatment-resistant Depression

AU - Schlaepfer, Thomas E.

AU - Kayser, Sarah

PY - 2013/2/5

Y1 - 2013/2/5

N2 - In approximately 50% of patients suffering from major depressive disorder (MDD), first-line antidepressant treatment is ineffective, and in about 30% of MDD patients, even four treatment steps yield insufficient antidepressant response. Stimulation of the human cerebral cortex with electrical currents was first described in 1874. In 1938, electroconvulsive therapy (ECT) was first used for the treatment of depression and about 50 years later transcranial magnetic stimulation (TMS) for the same purpose was successfully accomplished. Today, ECT is established as one of the main columns in treatment-resistant depression (TRD) therapy. However, due to cognitive side effects and stigmatization, ECT is often used as a treatment of last resort. In recent years, novel techniques using electrical and magnetic fields to stimulate the brain have been developed. This chapter examines the use of ECT, TMS, vagus nerve stimulation (VNS), deep-brain stimulation (DBS) and magnetic seizure therapy (MST).

AB - In approximately 50% of patients suffering from major depressive disorder (MDD), first-line antidepressant treatment is ineffective, and in about 30% of MDD patients, even four treatment steps yield insufficient antidepressant response. Stimulation of the human cerebral cortex with electrical currents was first described in 1874. In 1938, electroconvulsive therapy (ECT) was first used for the treatment of depression and about 50 years later transcranial magnetic stimulation (TMS) for the same purpose was successfully accomplished. Today, ECT is established as one of the main columns in treatment-resistant depression (TRD) therapy. However, due to cognitive side effects and stigmatization, ECT is often used as a treatment of last resort. In recent years, novel techniques using electrical and magnetic fields to stimulate the brain have been developed. This chapter examines the use of ECT, TMS, vagus nerve stimulation (VNS), deep-brain stimulation (DBS) and magnetic seizure therapy (MST).

KW - Brain stimulation methods

KW - Deep brain stimulation

KW - Electroconvulsive therapy

KW - Magnetic seizure therapy

KW - Transcranial magnetic stimulation

KW - Vagus nerve stimulation

UR - http://www.scopus.com/inward/record.url?scp=84886986146&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84886986146&partnerID=8YFLogxK

U2 - 10.1002/9781118556719.ch7

DO - 10.1002/9781118556719.ch7

M3 - Chapter

AN - SCOPUS:84886986146

SN - 9781119952909

SP - 159

EP - 182

BT - Treatment-resistant Depression

PB - John Wiley and Sons

ER -